Xtl Biopharmaceuticals (XTLB) Return on Assets [ROA] (2009 - 2024)
Xtl Biopharmaceuticals (XTLB) reported Return on Assets [ROA] of -159.91% for the year ended Dec 31, 2025, down 141.20 percentage points from -18.71% a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Return on Assets [ROA] (2009 - 2024) Analysis & Trends
Dating back to the year ended Dec 31, 2009, Xtl Biopharmaceuticals' Return on Assets [ROA] record includes 17 years.
- Return on Assets [ROA] has a five-year change of -116.84 percentage points (years ended Dec 2020 to Dec 2025).
- The figure for the year ended Dec 31, 2025 ranks as the lowest annual Return on Assets [ROA] in data going back to the year ended Dec 31, 2009.
- According to Business Quant data, Return on Assets [ROA] came in at -18.71% in the year ended Dec 31, 2024 (+35.19 pp), -53.90% in the year ended Dec 31, 2023 (-28.95 pp), -24.95% in the year ended Dec 31, 2022 (-31.58 pp) and 6.63% in the year ended Dec 31, 2021 (+49.71 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Xtl Biopharmaceuticals | 2.27 Bn | 2.27 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -15.75% |
| Sep 30, 2024 | -24.54% |
| Jun 30, 2024 | -41.12% |
| Mar 31, 2024 | -31.27% |
| Dec 31, 2023 | -35.88% |
| Sep 30, 2023 | -49.68% |
| Jun 30, 2023 | -63.94% |
| Mar 31, 2023 | -56.07% |
| Dec 31, 2022 | -46.31% |
| Sep 30, 2022 | -30.81% |
| Jun 30, 2022 | -16.64% |
| Mar 31, 2022 | -28.63% |
| Dec 31, 2021 | -24.43% |
| Sep 30, 2021 | -19.70% |
| Jun 30, 2021 | -16.12% |
| Mar 31, 2021 | -16.00% |
| Dec 31, 2020 | -17.38% |
| Sep 30, 2020 | -37.73% |
| Jun 30, 2020 | -34.88% |
| Mar 31, 2020 | -18.60% |
API Access
Xtl Biopharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();